115 related articles for article (PubMed ID: 11605008)
21. The fractional excretion of soluble interleukin-2 receptor-alpha is an excellent predictor of the interleukin-2 receptor-alpha status after treatment with daclizumab.
ter Meulen CG; Jacobs CW; Wetzels JF; Klasen IS; Hilbrands LB; Hoitsma AJ
Transplantation; 2004 Jan; 77(2):281-6. PubMed ID: 14742994
[TBL] [Abstract][Full Text] [Related]
22. Inhibiting IL-2 signaling and the regulatory T-cell pathway using computationally designed peptides.
Price-Troska T; Yang ZZ; Diller D; Bayden A; Jarosinski M; Audie J; Ansell SM
Invest New Drugs; 2019 Feb; 37(1):9-16. PubMed ID: 29696509
[TBL] [Abstract][Full Text] [Related]
23. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
Bien E; Balcerska A
Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
[TBL] [Abstract][Full Text] [Related]
24. Serum concentrations of soluble interleukin-2 receptor in patients with malignant brain tumors.
Yoshida S; Morii K
J Surg Oncol; 2000 Oct; 75(2):131-5. PubMed ID: 11064393
[TBL] [Abstract][Full Text] [Related]
25. Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration.
Hu H; Tang KF; Chua YN; Lu J; Feng P; Chew CT; Chan SH
Hum Pathol; 2004 Jun; 35(6):722-8. PubMed ID: 15188138
[TBL] [Abstract][Full Text] [Related]
26. Unconjugated Bilirubin Is a Novel Prognostic Biomarker for Nasopharyngeal Carcinoma and Inhibits Its Metastasis via Antioxidation Activity.
Deng CC; Xu M; Li J; Luo XL; Zhu YJ; Jiang R; Zhang MX; Lei JJ; Lian YF; Zou X; You R; Chen LZ; Feng QS; Bei JX; Chen MY; Zeng YX
Cancer Prev Res (Phila); 2016 Feb; 9(2):180-8. PubMed ID: 26407680
[TBL] [Abstract][Full Text] [Related]
27. Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma.
Jo SA; Hwang SH; Chang CL; Kim SY; Shin HJ; Chung JS; Sol MY; Lee EY
Korean J Lab Med; 2010 Dec; 30(6):600-5. PubMed ID: 21157146
[TBL] [Abstract][Full Text] [Related]
28. Soluble interleukin-2 receptor α activation in a Children's Oncology Group randomized trial of interleukin-2 therapy for pediatric acute myeloid leukemia.
Lange BJ; Yang RK; Gan J; Hank JA; Sievers EL; Alonzo TA; Gerbing RB; Sondel PM
Pediatr Blood Cancer; 2011 Sep; 57(3):398-405. PubMed ID: 21681921
[TBL] [Abstract][Full Text] [Related]
29. G-CSF therapy and catheter-related Gram-positive sepsis increase serum IL-2 receptor α level and may falsely suggest a relapse in children with soft tissue sarcomas unless serum beta2-microglobulin, lactate dehydrogenase and C-reactive protein levels are determined concomitantly.
Bien E; Balcerska A; Niedzwiecki M; Krawczyk M; Rapala M; Trzonkowski P; Stepinski J
Cytokine; 2011 Sep; 55(3):347-52. PubMed ID: 21640605
[TBL] [Abstract][Full Text] [Related]
30. Efficient ablation by immunotoxin-mediated cell targeting of the cell types that express human interleukin-2 receptor depending on the internal ribosome entry site.
Kobayashi T; Kida Y; Kaneko T; Pastan I; Kobayashi K
J Gene Med; 2001; 3(5):505-10. PubMed ID: 11601764
[TBL] [Abstract][Full Text] [Related]
31. The soluble IL-2 receptor α/CD25 as a modulator of IL-2 function.
Lokau J; Petasch LM; Garbers C
Immunology; 2024 Mar; 171(3):377-387. PubMed ID: 38037265
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
Hsiao SH; Lee MS; Lin HY; Su YC; Ho HC; Hwang JH; Lee CC; Hung SK
Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
[TBL] [Abstract][Full Text] [Related]
33. Abnormal regulation of soluble and anchored IL-6 receptor in monocytes from patients with essential thrombocythemia.
Goette NP; Lev PR; Heller PG; Glembotsky AC; Chazarreta CD; Salim JP; Molinas FC; Marta RF
Exp Hematol; 2010 Oct; 38(10):868-876.e1. PubMed ID: 20600579
[TBL] [Abstract][Full Text] [Related]
34. Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host disease.
Kokalj A; Greinix HT; Ciovica M; Kittler H; Kalhs P; Knobler RM; Volc-Platzer B
Clin Immunol; 2002 Sep; 104(3):248-55. PubMed ID: 12217335
[TBL] [Abstract][Full Text] [Related]
35. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
[TBL] [Abstract][Full Text] [Related]
36. Macrophage migration inhibitory factor enhances neoplastic cell invasion by inducing the expression of matrix metalloproteinase 9 and interleukin-8 in nasopharyngeal carcinoma cell lines.
Li Z; Ren Y; Wu QC; Lin SX; Liang YJ; Liang HZ
Chin Med J (Engl); 2004 Jan; 117(1):107-14. PubMed ID: 14733785
[TBL] [Abstract][Full Text] [Related]
37. Elevated soluble IL-2Rα, IL-8, and MIP-1β levels are associated with inferior outcome and are independent of MIPI score in patients with mantle cell lymphoma.
Sonbol MB; Maurer MJ; Stenson MJ; Allmer C; LaPlant BR; Weiner GJ; Macon WR; Cerhan JR; Witzig TE; Gupta M
Am J Hematol; 2014 Dec; 89(12):E223-7. PubMed ID: 25164110
[TBL] [Abstract][Full Text] [Related]
38. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
[TBL] [Abstract][Full Text] [Related]
39. Methods to avoid adverse effect of circulating antigen on biodistribution of 125I-labeled antiTac dsFv: preinjection of intact antibody versus clearance of antigen with adivin-biotin system.
Kobayashi H; Sun BF; Yoo TM; Le N; Kim MK; Paik CH; Pastan I; Waldmann TA; Carrasquillo JA
J Nucl Med; 1999 Aug; 40(8):1381-91. PubMed ID: 10450692
[TBL] [Abstract][Full Text] [Related]
40. Expression of interleukin-8, interleukin-10 and Epstein-Barr viral-load as prognostic indicator in nasopharyngeal carcinoma.
Savitri E; Haryana MS
Glob J Health Sci; 2015 Apr; 7(3):364-72. PubMed ID: 25948470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]